119 related articles for article (PubMed ID: 20175823)
1. CD163 expression in leukemia cutis.
Harms PW; Bandarchi B; Ma L
J Cutan Pathol; 2010 Sep; 37(9):953-7. PubMed ID: 20175823
[TBL] [Abstract][Full Text] [Related]
2. CD163: a specific marker of macrophages in paraffin-embedded tissue samples.
Lau SK; Chu PG; Weiss LM
Am J Clin Pathol; 2004 Nov; 122(5):794-801. PubMed ID: 15491976
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of monocytic leukemias: usefulness of CD14 and Kruppel-like factor 4, a novel monocyte marker.
Klco JM; Kulkarni S; Kreisel FH; Nguyen TD; Hassan A; Frater JL
Am J Clin Pathol; 2011 May; 135(5):720-30. PubMed ID: 21502426
[TBL] [Abstract][Full Text] [Related]
4. Myeloid leukemia cutis: a histologic and immunohistochemical review.
Cibull TL; Thomas AB; O'Malley DP; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):180-5. PubMed ID: 18190442
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of CD163 in cutaneous spindle cell lesions.
Pouryazdanparast P; Yu L; Cutlan JE; Olsen SH; Fullen DR; Ma L
J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
[TBL] [Abstract][Full Text] [Related]
6. CD163: a specific immunohistochemical marker for acute myeloid leukemia with monocytic differentiation.
Garcia C; Gardner D; Reichard KK
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):417-21. PubMed ID: 18542032
[TBL] [Abstract][Full Text] [Related]
7. Functional expression of the CD163 scavenger receptor on acute myeloid leukemia cells of monocytic lineage.
Bächli EB; Schaer DJ; Walter RB; Fehr J; Schoedon G
J Leukoc Biol; 2006 Feb; 79(2):312-8. PubMed ID: 16368951
[TBL] [Abstract][Full Text] [Related]
8. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
[TBL] [Abstract][Full Text] [Related]
9. Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
Sundram UN; Natkunam Y
J Cutan Pathol; 2007 Apr; 34(4):289-95. PubMed ID: 17381798
[TBL] [Abstract][Full Text] [Related]
10. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
11. CD163 is not a sensitive marker for identification of atypical fibroxanthoma.
Beer TW
J Cutan Pathol; 2012 Jan; 39(1):29-32. PubMed ID: 22211334
[TBL] [Abstract][Full Text] [Related]
12. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases.
Bénet C; Gomez A; Aguilar C; Delattre C; Vergier B; Beylot-Barry M; Fraitag S; Carlotti A; Dechelotte P; Hospital V; d'Incan M; Costes V; Dereure O; Ortonne N; Bagot M; Laroche L; Blom A; Dalac S; Petrella T
Am J Clin Pathol; 2011 Feb; 135(2):278-90. PubMed ID: 21228369
[TBL] [Abstract][Full Text] [Related]
13. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Sachdev R; Sundram U
J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
[TBL] [Abstract][Full Text] [Related]
15. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
16. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
17. The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias.
Rollins-Raval MA; Roth CG
Histopathology; 2012 May; 60(6):933-42. PubMed ID: 22348485
[TBL] [Abstract][Full Text] [Related]
18. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.
Nguyen TT; Schwartz EJ; West RB; Warnke RA; Arber DA; Natkunam Y
Am J Surg Pathol; 2005 May; 29(5):617-24. PubMed ID: 15832085
[TBL] [Abstract][Full Text] [Related]
20. Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis.
Su WP
Semin Dermatol; 1994 Sep; 13(3):223-30. PubMed ID: 7986692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]